SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Biotechnology Value Fund LP – ‘SC 13D/A’ on 3/5/24 re: MoonLake Immunotherapeutics

On:  Tuesday, 3/5/24, at 4:59pm ET   ·   Accession #:  921895-24-582   ·   File #:  5-91803

Previous ‘SC 13D’:  ‘SC 13D/A’ on 1/29/24   ·   Latest ‘SC 13D’:  This Filing

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/05/24  Biotechnology Value Fund LP       SC 13D/A               1:290K MoonLake Immunotherapeutics       Olshan Frome Wolosky LLP

Amendment to Statement of Acquisition of Beneficial Ownership by an “Active” Investor   —   Schedule 13D   —   WA’68

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: SC 13D/A    Amendment No. 2 to Schedule 13D                     HTML    288K 




        
Filing Submission 0000921895-24-000582 – SGML Text

Original SGML Text submitted by:  Olshan Frome Wolosky LLP  (as Filing Agent) 

Show all <DOCUMENT> <TEXT> elements below – 290K                        Top    Bottom

<SUBMISSION>
<SECRELEASE-DATETIME>		20240305-165948	 Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20240305-165946	 Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20240305-165916	 Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0000921895-24-000582
<TYPE>				SC 13D/A
<PUBLIC-DOCUMENT-COUNT>		1
<FILING-DATE>			20240305
<DATE-OF-FILING-DATE-CHANGE>	20240305
<SUBJECT-COMPANY>
<COMPANY-DATA>
<CONFORMED-NAME>		MoonLake Immunotherapeutics
<CIK>				0001821586
<ASSIGNED-SIC>			2834
<ORGANIZATION-NAME>		03 Life Sciences
<IRS-NUMBER>			000000000
<STATE-OF-INCORPORATION>	E9  This is an SEC Country/Territory Code for
				Cayman Islands [ U.K. ] {KY|CYM}
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			SC 13D/A
<ACT>				34
<FILE-NUMBER>			005-91803
<FILM-NUMBER>			24721877
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			DORFSTRASSE 29
<CITY>				ZUG
<STATE>				V8  This is an SEC Country/Territory Code for
				Switzerland {CH|CHE}
<ZIP>				6300
<PHONE>				41 41 510 8022
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			DORFSTRASSE 29
<CITY>				ZUG
<STATE>				V8  This is an SEC Country/Territory Code for
				Switzerland {CH|CHE}
<ZIP>				6300
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		Helix Acquisition Corp
<DATE-CHANGED>			20200818
</FORMER-COMPANY>
</SUBJECT-COMPANY>
<FILED-BY>
<COMPANY-DATA>
<CONFORMED-NAME>		BIOTECHNOLOGY VALUE FUND L P
<CIK>				0000918923
<ASSIGNED-SIC>			6282
<ORGANIZATION-NAME>		02 Finance
<IRS-NUMBER>			363924731  36-3924731 or 363-92-4731
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			SC 13D/A
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			44 MONTGOMERY STREET
<STREET2>			40TH FL
<CITY>				SAN FRANCISCO
<STATE>				CA
<ZIP>				94104
<PHONE>				3125066500
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			44 MONTGOMERY STREET
<STREET2>			40TH FL
<CITY>				SAN FRANCISCO
<STATE>				CA
<ZIP>				94104
</MAIL-ADDRESS>
</FILED-BY>
<DOCUMENT>
<TYPE>		SC 13D/A
<SEQUENCE>	1
<FILENAME>	sc13da207422mltx_03052024.htm
<DESCRIPTION>	AMENDMENT NO. 2 TO SCHEDULE 13D
<TEXT>
<html>
       Show <HTML>: 3,880 lines (widest: 388 characters) - 297K bytes  
</TEXT>
</DOCUMENT>
</SUBMISSION>
Top

Filing Submission 0000921895-24-000582   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sun., May 12, 8:25:49.5am ET